{"gene":"DGAT1","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":2000,"finding":"DGAT1 (Dgat) catalyzes the final and only committed step in triglyceride synthesis via the glycerol phosphate pathway; Dgat-deficient mice are viable and lean, demonstrating that Dgat1 is not absolutely required for survival but is necessary for normal triglyceride synthesis in adipose tissue and for lactation","method":"Genetic knockout (Dgat-/- mice), tissue triglyceride assays, phenotypic analysis of obesity resistance and lactation defects","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and physiological phenotypes, foundational study with >680 citations","pmids":["10802663"],"is_preprint":false},{"year":2005,"finding":"DGAT1 is a multifunctional acyltransferase: beyond triacylglycerol synthesis, it also catalyzes synthesis of diacylglycerols (monoacylglycerol acyltransferase activity), wax monoesters and wax diesters (wax synthase activity), and retinyl esters (acyl-CoA:retinol acyltransferase/ARAT activity) in vitro and in vivo","method":"In vitro acyltransferase assays with microsomes from insect cells and COS7 cells overexpressing DGAT1; intact cell assays; DGAT1-deficient mice showing reduced ARAT activity and elevated hepatic unesterified retinol","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — multiple in vitro enzymatic assays plus KO mouse validation, multiple orthogonal methods","pmids":["15834126"],"is_preprint":false},{"year":2010,"finding":"DGAT1 topology: three transmembrane domains with the N-terminus oriented toward the cytosol and the large C-terminal region (~50% of protein) residing in the ER lumen; a conserved histidine (His-426) in the luminal C-terminal domain is a putative active-site residue required for triacylglycerol, retinyl ester, and wax ester synthesis; the N-terminal domain is not required for catalytic activity but is involved in dimer/tetramer formation","method":"Protease protection assays, indirect immunofluorescence with selective membrane permeabilization, site-directed mutagenesis (H426A) with in vitro acyltransferase assays, N-terminal truncation mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple structural/topological methods combined with mutagenesis and enzymatic assays in a single study","pmids":["20876538"],"is_preprint":false},{"year":2005,"finding":"Liver-specific overexpression of DGAT1 increases DGAT activity detectable only in the presence of the permeabilizing agent alamethicin, indicating that DGAT1 possesses latent DGAT activity on the luminal face of the ER membrane; hepatic DGAT1 overexpression increases VLDL secretion, resulting in increased gonadal fat mass","method":"Adenovirus-mediated hepatic overexpression of DGAT1 in mice; DGAT activity assays with and without alamethicin permeabilization; plasma VLDL measurements; fat depot analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo gain-of-function with biochemical enzyme activity assays demonstrating luminal orientation","pmids":["15797871"],"is_preprint":false},{"year":2011,"finding":"DGAT1 and DGAT2 together account for nearly all triacylglycerol synthesis in adipocytes and are required for lipid droplet formation during adipogenesis; adipocytes lacking both DGATs have no TG or lipid droplets despite full differentiation; single deletion of either enzyme alone is insufficient to block TG synthesis","method":"Genetic double knockout (DGAT1 and DGAT2 adipocyte deletions), TG quantification, lipid droplet imaging, differentiation marker analysis","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via double KO with defined cellular phenotype, multiple methods","pmids":["21317108"],"is_preprint":false},{"year":2017,"finding":"FA re-esterification during adipocyte lipolysis is mediated specifically by DGAT1 (ER-localized); this re-esterification cycle does not preserve TG mass but instead protects the ER from lipotoxic stress and adipose tissue inflammation; mice lacking DGAT1 in adipocytes show activated ER stress pathways specifically under high-fat diet challenge","method":"Adipocyte-specific DGAT1 knockout mice, lipolysis assays, ER stress marker analysis, adipose tissue inflammation measurements, high-fat diet challenge","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with defined ER stress phenotype, replicated across multiple readouts","pmids":["28768178"],"is_preprint":false},{"year":2012,"finding":"In hepatocytes, DGAT1 preferentially esterifies exogenous (dietary/plasma) fatty acids into TG (re-esterification pathway), while DGAT2 primarily incorporates endogenously synthesized fatty acids into TG; DGAT1 inhibition reduces incorporation of exogenous oleic acid into VLDL-TG without affecting glycerol-derived (de novo) TG synthesis","method":"Stable isotope tracing with 13C3-D5-glycerol and 13C18-oleic acid in HepG2 cells; selective DGAT1 and DGAT2 inhibitors; in vivo D5-glycerol and 13C18-oleic acid tracing in mice with DGAT2 antisense oligonucleotide knockdown; LC-MS/MS lipidomics","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — isotope tracing with selective inhibitors in vitro and in vivo, multiple orthogonal methods","pmids":["22493088"],"is_preprint":false},{"year":2004,"finding":"The bovine DGAT1 K232A polymorphism is functionally causative: the K allele has higher Vmax for triglyceride production than the A allele, as demonstrated by baculovirus expression of both alleles in Sf9 cells","method":"Baculovirus expression system in Sf9 insect cells; DGAT enzymatic kinetics (Vmax) comparing K and A alleles; high-density SNP mapping confirming DGAT1 as QTL locus","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic reconstitution with allele comparison, replicated by genetic association","pmids":["14983021"],"is_preprint":false},{"year":2014,"finding":"Cardiomyocyte-specific loss of DGAT1 causes DAG and ceramide accumulation (95% and 85% increases respectively), heart failure, and early mortality; loss of DGAT1-mediated conversion of DAG to TG leads to increased PKCα activation by accumulated DAG/ceramides; restriction of dietary fat absorption via enterocyte-specific DGAT1 KO or GLP-1 agonist exenatide corrects these lipid abnormalities and cardiac dysfunction","method":"Cardiomyocyte-specific DGAT1 KO mice; DAG and ceramide quantification; cardiac function measurements (fractional shortening, BNP); genetic epistasis with enterocyte-specific Dgat1 KO; pharmacological treatment with exenatide","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO with defined lipid metabolite and cardiac phenotypes, epistasis rescue experiments","pmids":["25157099"],"is_preprint":false},{"year":2010,"finding":"DGAT1 expression in macrophages determines their TG storage capacity and inversely regulates inflammatory activation by saturated fatty acids; macrophage-specific DGAT1 overexpression protects against diet-induced adipose tissue inflammation and insulin resistance; PPARγ agonist protective effects against FA-induced macrophage inflammation are absent in Dgat1-null macrophages","method":"Bone marrow transplantation, macrophage-specific overexpression (aP2-Dgat1), macrophage isolation with TG measurement, inflammatory cytokine assays, PPARγ agonist treatment of Dgat1-null macrophages","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific overexpression and KO with BM transplantation epistasis and defined inflammatory phenotypes","pmids":["20124729"],"is_preprint":false},{"year":2010,"finding":"Intestinal DGAT1 stimulates dietary fat secretion out of enterocytes into circulation; intestinal DGAT1 expression alone (without liver or adipose DGAT1) is sufficient to reconstitute susceptibility to high-fat diet-induced hepatic steatosis and obesity in Dgat1-/- mice","method":"Intestine-specific rescue of DGAT1 expression in Dgat1-/- mice (Dgat1IntONLY), high-fat diet challenge, hepatic steatosis measurement, obesity phenotyping","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific rescue epistasis experiment with defined metabolic phenotype","pmids":["20147738"],"is_preprint":false},{"year":2012,"finding":"Intestinal DGAT1 inhibition or deficiency reduces postprandial TG and retinyl ester excursions by inhibiting chylomicron secretion; loss of intestinal DGAT1 activity delays gastric emptying and increases plasma GLP-1; the chylomicron secretion defect occurs independently of gastric emptying delay when lipid is delivered directly to the small intestine","method":"Intestine-specific Dgat1 KO mice, acute DGAT1 inhibitor gavage, oral fat/retinol loading, chylomicron secretion assays, GLP-1 measurement, duodenal oil injection bypass experiments","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — genetic KO combined with pharmacological inhibition and multiple mechanistic dissection experiments","pmids":["22911105"],"is_preprint":false},{"year":2018,"finding":"Hepatic DGAT1 determines VLDL particle size and TG content but not particle number; DGAT1-LKO hepatocytes secrete VLDL particles with half the normal TG content and size; this is consistent with DGAT1's dual ER membrane topology enabling TAG synthesis on the luminal side for full VLDL lipidation; DGAT2 can fully support apoB secretion (particle number) in absence of DGAT1","method":"Hepatocyte-specific DGAT1 KO mice (DGAT1-LKO), Triton WR-1339 VLDL secretion assay, VLDL particle sizing, apoB concentration measurement, ER lipid content analysis by electron microscopy, HepG2 cells with isoform-selective inhibitors","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — hepatocyte-specific KO with biochemical characterization of VLDL particles and ER lipid content, consistent with established topology","pmids":["30397187"],"is_preprint":false},{"year":2019,"finding":"DGAT1 and DGAT2 have distinct but overlapping functions in adipocytes: DGAT2-specific KO in adipocytes does not impair TG storage or glucose metabolism, while DGAT1-specific KO causes glucose intolerance and ER stress pathway activation on high-fat diets; DGAT1 uniquely protects the ER from lipotoxic stress of high-fat feeding","method":"Adipocyte-specific DGAT1 and DGAT2 KO mice, high-fat diet challenge, TG quantification, glucose tolerance tests, ER stress marker analysis","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — parallel cell-type-specific KO models with defined metabolic and ER stress phenotypes","pmids":["30936184"],"is_preprint":false},{"year":2004,"finding":"DGAT1 deficiency in mice impairs mammary gland development: decreased epithelial proliferation, alveolar development, and reduced expression of functional differentiation markers; transplantation studies show DGAT1 is required in both stromal and epithelial tissues for normal mammary development","method":"Dgat1-/- mice, mammary gland transplantation (wild-type vs. Dgat1-/- stroma/epithelium combinations), proliferation and differentiation marker analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — tissue transplantation epistasis with defined developmental phenotype","pmids":["15163627"],"is_preprint":false},{"year":2019,"finding":"DGAT1 acyltransferase activity sequesters retinol as retinyl esters, thereby preventing retinol conversion to retinoic acid and suppressing retinoic acid-dependent regulatory T cell (Treg) formation; DGAT1 inhibition or deficiency in T cells enhances Treg frequency and attenuates experimental autoimmune encephalomyelitis","method":"Dgat1-/- mice in EAE model, adoptive transfer of Dgat1-/- Th17 cells, DGAT1 inhibitor treatment, in vitro Treg induction assays with retinol, T cell-depleted lymphoid tissue cultures","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — KO and pharmacological inhibition with mechanistic retinol/retinoic acid pathway dissection in multiple in vitro and in vivo experiments","pmids":["30718413"],"is_preprint":false},{"year":2021,"finding":"HILPDA (hypoxia-inducible lipid droplet-associated protein) physically interacts with DGAT1 in living liver cells and stimulates DGAT activity, increasing DGAT1 protein levels and promoting lipid storage in hepatocytes and adipocytes","method":"FRET-FLIM in live cells confirming physical interaction, real-time fluorescence live-cell imaging, DGAT activity assays, HILPDA overexpression and deficiency models","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 — FRET-FLIM physical interaction in living cells plus functional enzymatic activity assays and KO/OE models","pmids":["33465519"],"is_preprint":false},{"year":2021,"finding":"SARS-CoV-2 nucleocapsid protein drives DGAT1/2 gene expression to facilitate lipid droplet formation; DGAT1 gene depletion reduces SARS-CoV-2 protein synthesis without compromising viral genome replication/transcription, indicating DGAT1-dependent lipid droplets are required for a post-replication step in the viral cycle","method":"DGAT gene depletion (siRNA/CRISPR), viral protein vs. genome replication quantification, lipid droplet imaging, DGAT inhibitor xanthohumol in hamster model","journal":"Cell discovery","confidence":"Medium","confidence_rationale":"Tier 2 — genetic depletion with mechanistic dissection of viral lifecycle steps, single lab study","pmids":["34702802"],"is_preprint":false},{"year":2015,"finding":"DGAT1 in skeletal muscle cells is phosphorylated at multiple sites; phosphorylation at specific conserved residues regulates DGAT1 enzymatic activity; a defined N-terminal domain of DGAT1 influences regulatory activity; these phosphorylation events were confirmed by mass spectrometry of purified DGAT1 from C2C12 myoblasts","method":"Phosphorylation mass spectrometry of purified DGAT1 from C2C12 cells, site-directed mutagenesis of phosphorylation sites, truncation mutants with enzymatic activity assays","journal":"Biophysics reports","confidence":"Medium","confidence_rationale":"Tier 1 — mass spectrometry identification combined with mutagenesis functional assays, single lab study","pmids":["26942218"],"is_preprint":false},{"year":2014,"finding":"DGAT1 substrate binding sites include a luminal loop containing the FYxDWWN motif (Sit1, shared with ACAT enzymes) that changes conformation upon binding both oleoyl-CoA and diacylglycerol substrates, and a diacylglycerol-binding domain (Sit2, HKWCIRHFYKP motif) that interacts with charged headgroups; in a peptide containing both sites, larger conformational changes are induced, suggesting the two sites bring substrates into proximity for catalysis","method":"Synchrotron radiation circular dichroism spectroscopy of synthetic peptides, fluorescence emission spectroscopy, lipid monolayer adsorption assays with substrates oleoyl-CoA and dioleoylglycerol","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 — multiple biophysical methods on defined peptides, but indirect (peptide-based) rather than full protein structure","pmids":["25152299"],"is_preprint":false},{"year":2017,"finding":"A novel DGAT1 missense mutation p.L105P causes partial loss of DGAT1 enzymatic activity and decreased TG synthesis and lipid droplet formation in patient-derived fibroblasts, demonstrating that DGAT1 protein stability and quantity affect TG synthesis capacity","method":"Exome sequencing, patient-derived primary dermal fibroblasts, DGAT1 protein abundance measurement, TG synthesis assays, lipid droplet quantification after oleic acid loading","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — patient-derived cell functional assays with defined biochemical readouts, single center","pmids":["28373485"],"is_preprint":false},{"year":2018,"finding":"Biallelic loss-of-function mutations in human DGAT1 cause intestinal failure with altered triacylglycerol metabolism, decreased lipid droplet formation, and increased susceptibility to lipid-induced cell death; expression of full-length DGAT2 in DGAT1-deficient fibroblasts restores lipid droplet formation, demonstrating functional overlap between the two enzymes","method":"Next-generation sequencing identifying 5 biallelic DGAT1 mutations, patient-derived intestinal organoids and fibroblasts, immunoblot, flow cytometry, lipid chromatography, caspase 3/7 activity assays, DGAT2 rescue experiments, CRISPR/Cas9 DGAT1 disruption in control organoids","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — multiple patient-derived cell systems with orthogonal methods plus rescue experiments, large patient cohort","pmids":["29604290"],"is_preprint":false},{"year":2004,"finding":"DGAT1 overexpression in skeletal muscle by in vivo electroporation directly increases intramyocellular lipid (IMCL) storage in a diet-responsive manner, demonstrating that DGAT1 activity directly controls TG storage in muscle","method":"In vivo DNA electroporation of pcDNA3.1-DGAT1 into tibialis anterior muscle, immunofluorescence for DGAT1 protein expression, quantitative IMCL analysis with lipid staining","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vivo gain-of-function with quantitative lipid phenotype, single lab","pmids":["15576838"],"is_preprint":false},{"year":2009,"finding":"DGAT1 in intestinal L-cells directly regulates GLP-1 and PYY secretion; DGAT1KO mice show prolonged GLP-1 and PYY elevation after triglyceride loading compared to wild-type, while GIP increase is suppressed; STC-1 and GLUTag L-cell lines possess DGAT1 activity but not MGAT activity","method":"DGAT1KO and MGAT2KO mouse oral triglyceride loading studies, plasma gut peptide measurements (GIP, GLP-1, PYY), gastric emptying measurements, DGAT/MGAT activity assays in L-cell lines","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse studies with biochemical cell-line validation, single lab","pmids":["19732742"],"is_preprint":false},{"year":2017,"finding":"Ghrelin deletion prevents age-associated DGAT1 upregulation in liver by reducing formation of C/EBPα-p300 transcriptional complexes that bind and activate the DGAT1 promoter; in aged wild-type mice, C/EBPα-p300 complexes bind the DGAT1 promoter and increase DGAT1 expression, driving steatosis","method":"Ghrelin KO mice, ChIP analysis showing C/EBPα-p300 occupancy of DGAT1 promoter, co-immunoprecipitation of C/EBPα-p300 complexes, DGAT1 promoter binding studies, aged mouse hepatic steatosis analysis","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and Co-IP demonstrating transcriptional complex binding to DGAT1 promoter, single lab","pmids":["29024407"],"is_preprint":false},{"year":2022,"finding":"In clear cell renal cell carcinoma, the epigenetic enzyme JMJD6 interacts with RBM39 and co-occupies the DGAT1 gene promoter with H3K4me3 to induce DGAT1 expression; DGAT1 upregulation promotes lipid droplet formation required for ccRCC tumorigenesis","method":"siRNA screen, ChIP-seq and RNA-seq integration, Co-IP of JMJD6-RBM39 interaction, DGAT1 KD and pharmacological inhibition, orthotopic tumor models in vivo","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq, Co-IP and in vivo tumor models in single study, mechanistic pathway defined","pmids":["35764091"],"is_preprint":false},{"year":2016,"finding":"In hepatic stellate cells, DGAT1 synthesizes newly formed TAG enriched in PUFAs; ATGL preferentially degrades these newly synthesized DGAT1-dependent TAGs; DGAT1 inhibitor T863 reduces PUFA-TAG synthesis in HSCs","method":"Targeted Atgl gene deletion in mouse HSCs, DGAT1 inhibitor T863, lipidomics of TAG species, hepatic stellate cell activation assays","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO combined with pharmacological inhibition and lipidomic characterization, single lab","pmids":["27179362"],"is_preprint":false},{"year":2019,"finding":"In DGAT1-deficient human intestinal stem cell organoids, DGAT2 partially compensates for lipid droplet formation; unsaturated and saturated FA-induced lipotoxicity in DGAT1-deficient cells is mediated by ER stress; DGAT2 overexpression fully rescues DGAT1 deficiency in organoids","method":"Patient-derived DGAT1-deficient intestinal organoids, DGAT2 overexpression rescue, ER stress marker analysis, lipid droplet quantification, FA lipotoxicity assays","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — patient-derived organoid rescue experiments with mechanistic ER stress pathway analysis, single lab","pmids":["31315900"],"is_preprint":false}],"current_model":"DGAT1 is an ER-resident integral membrane enzyme with three transmembrane domains and a large catalytic C-terminal domain in the ER lumen (containing the active-site His-426) that catalyzes the final committed step of triacylglycerol synthesis by acylating diacylglycerol using acyl-CoA; it also functions as a monoacylglycerol acyltransferase, wax synthase, and retinol acyltransferase (ARAT), and its dual ER topology enables both cytosolic and luminal TG synthesis—with the luminal activity being critical for full VLDL lipidation; beyond bulk TG storage, DGAT1 specifically re-esterifies exogenous fatty acids and protects the ER from lipotoxic stress during lipolysis, controls retinol availability for retinoic acid synthesis in T cells, regulates gut peptide (GLP-1/PYY) secretion in intestinal L-cells, and is transcriptionally regulated by C/EBPα-p300 complexes and the JMJD6-RBM39 epigenetic axis."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that DGAT1 is the terminal enzyme in the glycerol phosphate TG synthesis pathway and is required for normal adiposity and lactation—but is not essential for viability—defined its non-redundant physiological role and implied the existence of compensatory pathways.","evidence":"Dgat1 global knockout mice with phenotypic and tissue TG analysis","pmids":["10802663"],"confidence":"High","gaps":["Identity and contribution of the compensating enzyme (DGAT2) not yet defined","Tissue-specific requirements not resolved"]},{"year":2004,"claim":"Demonstration that DGAT1 directly controls intramyocellular and mammary lipid storage, and that a naturally occurring bovine K232A polymorphism alters enzymatic Vmax, established DGAT1 activity as rate-limiting for tissue TG content and showed genetic variation at the locus has quantitative functional consequences.","evidence":"In vivo muscle electroporation gain-of-function; mammary transplantation epistasis; baculovirus reconstitution of K vs A alleles with kinetic assays","pmids":["14983021","15576838","15163627"],"confidence":"High","gaps":["Post-translational regulation of DGAT1 activity unknown","Structural basis for K232A kinetic difference unresolved"]},{"year":2005,"claim":"Discovering DGAT1's multifunctional acyltransferase repertoire (MGAT, wax synthase, ARAT) and its latent luminal DGAT activity that promotes VLDL secretion revealed that the enzyme operates on both sides of the ER membrane and handles diverse lipid substrates.","evidence":"In vitro microsome assays with multiple substrates; Dgat1-KO mouse retinol metabolism; hepatic adenoviral overexpression with alamethicin-dependent activity assays and VLDL measurement","pmids":["15834126","15797871"],"confidence":"High","gaps":["Structural basis for multisubstrate promiscuity unknown","Relative contribution of luminal vs cytosolic activity in vivo not quantified"]},{"year":2009,"claim":"Identification that DGAT1 in intestinal L-cells regulates GLP-1 and PYY secretion linked TG esterification to gut incretin signaling, expanding DGAT1's role beyond lipid storage to neuroendocrine regulation.","evidence":"Dgat1-KO and Mgat2-KO mouse oral TG loading with gut peptide measurement; DGAT/MGAT activity assays in L-cell lines","pmids":["19732742"],"confidence":"Medium","gaps":["Mechanism by which intracellular TG flux regulates peptide vesicle secretion undefined","Contribution of DGAT1 vs other lipid metabolic steps in L-cells not fully separated"]},{"year":2010,"claim":"Elucidation of DGAT1 membrane topology (three TMDs, luminal catalytic domain with essential His-426) and demonstration that macrophage DGAT1 inversely controls inflammatory activation resolved how the enzyme is oriented in the ER and established a cell-autonomous anti-inflammatory function through FA sequestration.","evidence":"Protease protection, selective permeabilization, site-directed mutagenesis; bone marrow transplant with macrophage-specific overexpression and KO","pmids":["20876538","20124729","20147738"],"confidence":"High","gaps":["High-resolution 3D structure not available","Mechanism of oligomerization via N-terminal domain not fully defined"]},{"year":2011,"claim":"Double knockout of DGAT1 and DGAT2 in adipocytes completely abolished TG and lipid droplets while single knockouts did not, formally proving functional redundancy yet also demonstrating that the two enzymes together account for virtually all adipocyte TG synthesis.","evidence":"Adipocyte-specific double KO with TG quantification and lipid droplet imaging","pmids":["21317108"],"confidence":"High","gaps":["Whether the two enzymes occupy distinct ER subdomains not addressed","Lipid species specificity of each enzyme in adipocytes not resolved"]},{"year":2012,"claim":"Isotope tracing established that DGAT1 preferentially esterifies exogenous fatty acids while DGAT2 handles de novo–synthesized ones, and that intestinal DGAT1 is required for chylomicron secretion independently of gastric emptying, delineating substrate-source partitioning between the two enzymes.","evidence":"13C-oleic acid and 13C3-D5-glycerol tracing with isoform-selective inhibitors in HepG2 and mice; intestine-specific Dgat1 KO with duodenal oil bypass","pmids":["22493088","22911105"],"confidence":"High","gaps":["Molecular determinants of exogenous FA channeling to DGAT1 unknown","Whether FA source specificity holds in all tissues untested"]},{"year":2014,"claim":"Biophysical characterization of substrate-binding motifs (FYxDWWN and HKWCIRHFYKP) and demonstration that cardiomyocyte DGAT1 loss causes lethal DAG/ceramide accumulation and heart failure provided the first structure-function mapping of the active site and revealed that DGAT1-mediated DAG clearance is essential for cardiac lipid homeostasis.","evidence":"Synchrotron CD and fluorescence spectroscopy of synthetic peptides; cardiomyocyte-specific Dgat1 KO with lipidomics and cardiac function measurement","pmids":["25152099","25157099"],"confidence":"High","gaps":["Peptide-based substrate binding studies not validated in full-length protein","How cardiac DGAT1 is regulated differently from adipocyte DGAT1 unclear"]},{"year":2017,"claim":"Discovery that DGAT1-mediated fatty acid re-esterification during lipolysis specifically protects the ER from lipotoxic stress—rather than preserving TG mass—redefined the enzyme's role as an ER quality-control mechanism, while identification of C/EBPα–p300 complex binding at the DGAT1 promoter established a transcriptional regulatory axis.","evidence":"Adipocyte-specific Dgat1 KO with ER stress markers under HFD; ChIP and Co-IP of C/EBPα–p300 on DGAT1 promoter in aged mouse liver","pmids":["28768178","29024407"],"confidence":"High","gaps":["Specific ER lipid species causing stress in DGAT1-deficient cells not identified","Whether C/EBPα–p300 regulation is universal or tissue-specific unknown"]},{"year":2018,"claim":"Hepatocyte-specific DGAT1 deletion showed that DGAT1 determines VLDL particle size and TG content (but not particle number), linking the enzyme's luminal activity to the second-step lipidation of VLDL; separately, biallelic human DGAT1 mutations were shown to cause congenital intestinal failure with lipotoxic cell death, establishing DGAT1 deficiency as a Mendelian disease.","evidence":"DGAT1-LKO mice with VLDL particle sizing; patient-derived organoids and fibroblasts from five DGAT1-mutant families with DGAT2 rescue and CRISPR validation","pmids":["30397187","29604290"],"confidence":"High","gaps":["How luminal TG pool is transferred to nascent VLDL particles mechanistically unresolved","Genotype-phenotype correlation across different human mutations not established"]},{"year":2019,"claim":"Demonstration that DGAT1's ARAT activity sequesters retinol away from retinoic acid synthesis in T cells, thereby suppressing Treg differentiation, revealed an unexpected immunoregulatory function linking lipid metabolism to adaptive immunity.","evidence":"Dgat1-KO mice in EAE model, adoptive T cell transfer, DGAT1 inhibitor, in vitro Treg induction with retinol","pmids":["30718413"],"confidence":"High","gaps":["Whether DGAT1-dependent retinol esterification regulates other immune cell types untested","Relative contribution of DGAT1 ARAT vs LRAT in T cell retinol homeostasis not quantified"]},{"year":2021,"claim":"Identification of HILPDA as a direct physical interactor that stimulates DGAT1 activity provided the first protein-level positive regulator of the enzyme, suggesting allosteric or stabilizing activation mechanisms.","evidence":"FRET-FLIM in live hepatocytes confirming physical interaction; DGAT activity assays with HILPDA OE/KO","pmids":["33465519"],"confidence":"High","gaps":["Binding interface and mechanism of HILPDA-mediated activation undefined","Whether HILPDA affects DGAT1 oligomeric state unknown"]},{"year":2022,"claim":"Discovery that the JMJD6–RBM39 epigenetic complex co-occupies the DGAT1 promoter with H3K4me3 to drive DGAT1 expression in clear cell renal cell carcinoma established a second transcriptional regulatory axis and implicated DGAT1-dependent lipid droplets in tumor biology.","evidence":"ChIP-seq, RNA-seq, Co-IP of JMJD6–RBM39, DGAT1 KD and inhibition in orthotopic ccRCC tumor models","pmids":["35764091"],"confidence":"Medium","gaps":["Whether JMJD6–RBM39 regulation of DGAT1 occurs in non-malignant tissues unknown","Mechanism by which DGAT1-dependent LDs support ccRCC viability not resolved"]},{"year":null,"claim":"A high-resolution structure of full-length DGAT1 in complex with substrates and regulatory partners (e.g., HILPDA) is needed to explain multisubstrate promiscuity, the structural basis for oligomerization, and how phosphorylation at identified sites modulates activity.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length human DGAT1 structure with substrates bound","Phosphorylation-dependent regulation not integrated with topology and structural models","Allosteric mechanism of HILPDA activation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[19]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,3,5]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,4,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[15]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[3,12]}],"complexes":[],"partners":["HILPDA","DGAT2","CEBPA","EP300","JMJD6","RBM39"],"other_free_text":[]},"mechanistic_narrative":"DGAT1 is an ER-resident acyltransferase that catalyzes the final committed step of triacylglycerol (TG) synthesis and additionally functions as a monoacylglycerol acyltransferase, wax synthase, and retinol acyltransferase (ARAT), with a catalytic His-426 residue in its large ER-luminal C-terminal domain [PMID:15834126, PMID:20876538]. Its dual ER membrane topology enables both cytosolic and luminal TG synthesis; the luminal activity is specifically required for full VLDL lipidation in hepatocytes and for chylomicron secretion in enterocytes, while it preferentially esterifies exogenous rather than de novo–synthesized fatty acids [PMID:15797871, PMID:30397187, PMID:22493088]. Beyond bulk lipid storage, DGAT1-mediated re-esterification of fatty acids released during lipolysis protects the ER from lipotoxic stress, and its ARAT activity controls retinol availability for retinoic acid–dependent regulatory T cell differentiation [PMID:28768178, PMID:30936184, PMID:30718413]. Biallelic loss-of-function mutations in human DGAT1 cause congenital diarrhea and intestinal failure with impaired TG metabolism and increased susceptibility to lipid-induced cell death [PMID:29604290]."},"prefetch_data":{"uniprot":{"accession":"O75907","full_name":"Diacylglycerol O-acyltransferase 1","aliases":["ACAT-related gene product 1","Acyl-CoA retinol O-fatty-acyltransferase","ARAT","Retinol O-fatty-acyltransferase","Diglyceride acyltransferase"],"length_aa":488,"mass_kda":55.3,"function":"Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates (PubMed:16214399, PubMed:18768481, PubMed:28420705, PubMed:32433610, PubMed:32433611, PubMed:9756920). Highly expressed in epithelial cells of the small intestine and its activity is essential for the absorption of dietary fats (PubMed:18768481). In liver, plays a role in esterifying exogenous fatty acids to glycerol, and is required to synthesize fat for storage (PubMed:16214399). Also present in female mammary glands, where it produces fat in the milk (By similarity). May be involved in VLDL (very low density lipoprotein) assembly (PubMed:18768481). In contrast to DGAT2 it is not essential for survival (By similarity). Functions as the major acyl-CoA retinol acyltransferase (ARAT) in the skin, where it acts to maintain retinoid homeostasis and prevent retinoid toxicity leading to skin and hair disorders (PubMed:16214399). Exhibits additional acyltransferase activities, includin acyl CoA:monoacylglycerol acyltransferase (MGAT), wax monoester and wax diester synthases (By similarity). Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG) (PubMed:28420705)","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/O75907/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DGAT1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DGAT1","total_profiled":1310},"omim":[{"mim_id":"621380","title":"TRANSMEMBRANE PROTEIN 68; TMEM68","url":"https://www.omim.org/entry/621380"},{"mim_id":"615863","title":"DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7","url":"https://www.omim.org/entry/615863"},{"mim_id":"610270","title":"MONOACYLGLYCEROL O-ACYLTRANSFERASE 2; MOGAT2","url":"https://www.omim.org/entry/610270"},{"mim_id":"610268","title":"MONOACYLGLYCEROL O-ACYLTRANSFERASE 1; MOGAT1","url":"https://www.omim.org/entry/610268"},{"mim_id":"609532","title":"HEPATITIS C VIRUS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/609532"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Nucleoli rim","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":41.8}],"url":"https://www.proteinatlas.org/search/DGAT1"},"hgnc":{"alias_symbol":["ARGP1"],"prev_symbol":["DGAT"]},"alphafold":{"accession":"O75907","domains":[{"cath_id":"-","chopping":"124-226_239-256","consensus_level":"high","plddt":90.9499,"start":124,"end":256},{"cath_id":"-","chopping":"270-486","consensus_level":"medium","plddt":89.6886,"start":270,"end":486}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75907","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75907-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75907-F1-predicted_aligned_error_v6.png","plddt_mean":80.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DGAT1","jax_strain_url":"https://www.jax.org/strain/search?query=DGAT1"},"sequence":{"accession":"O75907","fasta_url":"https://rest.uniprot.org/uniprotkb/O75907.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75907/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75907"}},"corpus_meta":[{"pmid":"18757836","id":"PMC_18757836","title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.","date":"2008","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/18757836","citation_count":843,"is_preprint":false},{"pmid":"10802663","id":"PMC_10802663","title":"Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10802663","citation_count":680,"is_preprint":false},{"pmid":"16920778","id":"PMC_16920778","title":"Tung tree DGAT1 and DGAT2 have nonredundant functions in triacylglycerol biosynthesis and are localized to different subdomains of the endoplasmic reticulum.","date":"2006","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/16920778","citation_count":392,"is_preprint":false},{"pmid":"28768178","id":"PMC_28768178","title":"Triglyceride Synthesis by DGAT1 Protects Adipocytes from Lipid-Induced ER Stress during Lipolysis.","date":"2017","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28768178","citation_count":275,"is_preprint":false},{"pmid":"21317108","id":"PMC_21317108","title":"DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21317108","citation_count":268,"is_preprint":false},{"pmid":"14983021","id":"PMC_14983021","title":"Genetic and functional confirmation of the causality of the DGAT1 K232A quantitative trait nucleotide in affecting milk yield and composition.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14983021","citation_count":267,"is_preprint":false},{"pmid":"32559414","id":"PMC_32559414","title":"Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32559414","citation_count":266,"is_preprint":false},{"pmid":"18278045","id":"PMC_18278045","title":"A phenylalanine in DGAT is a key determinant of oil content and composition in maize.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18278045","citation_count":252,"is_preprint":false},{"pmid":"15834126","id":"PMC_15834126","title":"The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters.","date":"2005","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15834126","citation_count":215,"is_preprint":false},{"pmid":"20124729","id":"PMC_20124729","title":"DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation.","date":"2010","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20124729","citation_count":190,"is_preprint":false},{"pmid":"19116371","id":"PMC_19116371","title":"Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.","date":"2008","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19116371","citation_count":176,"is_preprint":false},{"pmid":"15258194","id":"PMC_15258194","title":"Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells.","date":"2004","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15258194","citation_count":174,"is_preprint":false},{"pmid":"20051035","id":"PMC_20051035","title":"Tobacco as a production platform for biofuel: overexpression of Arabidopsis DGAT and LEC2 genes increases accumulation and shifts the composition of lipids in green biomass.","date":"2009","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/20051035","citation_count":155,"is_preprint":false},{"pmid":"30077544","id":"PMC_30077544","title":"Role of DGAT enzymes in triacylglycerol metabolism.","date":"2018","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/30077544","citation_count":148,"is_preprint":false},{"pmid":"21933415","id":"PMC_21933415","title":"Evolutionary view of acyl-CoA diacylglycerol acyltransferase (DGAT), a key enzyme in neutral lipid biosynthesis.","date":"2011","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/21933415","citation_count":145,"is_preprint":false},{"pmid":"30936184","id":"PMC_30936184","title":"The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes.","date":"2019","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/30936184","citation_count":138,"is_preprint":false},{"pmid":"16894240","id":"PMC_16894240","title":"The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment.","date":"2006","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/16894240","citation_count":135,"is_preprint":false},{"pmid":"14510671","id":"PMC_14510671","title":"DGAT1, a new positional and functional candidate gene for intramuscular fat deposition in cattle.","date":"2003","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14510671","citation_count":124,"is_preprint":false},{"pmid":"12926772","id":"PMC_12926772","title":"Effects of DGAT1 variants on milk production traits in German cattle breeds.","date":"2003","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/12926772","citation_count":119,"is_preprint":false},{"pmid":"15797871","id":"PMC_15797871","title":"Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15797871","citation_count":119,"is_preprint":false},{"pmid":"20876538","id":"PMC_20876538","title":"Topological orientation of acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) and identification of a putative active site histidine and the role of the n terminus in dimer/tetramer formation.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20876538","citation_count":118,"is_preprint":false},{"pmid":"36084349","id":"PMC_36084349","title":"Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36084349","citation_count":117,"is_preprint":false},{"pmid":"12512625","id":"PMC_12512625","title":"Characterization of the DGAT1 gene in the New Zealand dairy population.","date":"2002","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/12512625","citation_count":98,"is_preprint":false},{"pmid":"20439724","id":"PMC_20439724","title":"A distinct DGAT with sn-3 acetyltransferase activity that synthesizes unusual, reduced-viscosity oils in Euonymus and transgenic seeds.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20439724","citation_count":98,"is_preprint":false},{"pmid":"21515696","id":"PMC_21515696","title":"ABI4 activates DGAT1 expression in Arabidopsis seedlings during nitrogen deficiency.","date":"2011","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21515696","citation_count":94,"is_preprint":false},{"pmid":"22493088","id":"PMC_22493088","title":"The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22493088","citation_count":93,"is_preprint":false},{"pmid":"29604290","id":"PMC_29604290","title":"Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency.","date":"2018","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/29604290","citation_count":92,"is_preprint":false},{"pmid":"20597032","id":"PMC_20597032","title":"DGAT1 inhibitors as anti-obesity and anti-diabetic agents.","date":"2010","source":"Current opinion in drug discovery & development","url":"https://pubmed.ncbi.nlm.nih.gov/20597032","citation_count":90,"is_preprint":false},{"pmid":"24272998","id":"PMC_24272998","title":"Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it.","date":"2014","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/24272998","citation_count":85,"is_preprint":false},{"pmid":"25157099","id":"PMC_25157099","title":"Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25157099","citation_count":70,"is_preprint":false},{"pmid":"21205704","id":"PMC_21205704","title":"DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21205704","citation_count":69,"is_preprint":false},{"pmid":"23942253","id":"PMC_23942253","title":"ABA-insensitive (ABI) 4 and ABI5 synergistically regulate DGAT1 expression in Arabidopsis seedlings under stress.","date":"2013","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/23942253","citation_count":68,"is_preprint":false},{"pmid":"20147738","id":"PMC_20147738","title":"Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20147738","citation_count":66,"is_preprint":false},{"pmid":"23143182","id":"PMC_23143182","title":"Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle.","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23143182","citation_count":61,"is_preprint":false},{"pmid":"15190946","id":"PMC_15190946","title":"DGAT1 polymorphism in Bos indicus and Bos taurus cattle breeds.","date":"2004","source":"The Journal of dairy research","url":"https://pubmed.ncbi.nlm.nih.gov/15190946","citation_count":60,"is_preprint":false},{"pmid":"33465519","id":"PMC_33465519","title":"Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33465519","citation_count":58,"is_preprint":false},{"pmid":"29660088","id":"PMC_29660088","title":"The MYB96 Transcription Factor Regulates Triacylglycerol Accumulation by Activating DGAT1 and PDAT1 Expression in Arabidopsis Seeds.","date":"2018","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29660088","citation_count":57,"is_preprint":false},{"pmid":"22911105","id":"PMC_22911105","title":"Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22911105","citation_count":57,"is_preprint":false},{"pmid":"23539042","id":"PMC_23539042","title":"Activities of acyl-CoA:diacylglycerol acyltransferase (DGAT) and phospholipid:diacylglycerol acyltransferase (PDAT) in microsomal preparations of developing sunflower and safflower seeds.","date":"2013","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/23539042","citation_count":56,"is_preprint":false},{"pmid":"15224651","id":"PMC_15224651","title":"The role of acyl-CoA:diacylglycerol acyltransferase (DGAT) in energy metabolism.","date":"2004","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15224651","citation_count":55,"is_preprint":false},{"pmid":"19732742","id":"PMC_19732742","title":"Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19732742","citation_count":55,"is_preprint":false},{"pmid":"32732347","id":"PMC_32732347","title":"Oil-Producing Metabolons Containing DGAT1 Use Separate Substrate Pools from those Containing DGAT2 or PDAT.","date":"2020","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32732347","citation_count":52,"is_preprint":false},{"pmid":"34702802","id":"PMC_34702802","title":"SARS-CoV-2 exploits host DGAT and ADRP for efficient replication.","date":"2021","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34702802","citation_count":47,"is_preprint":false},{"pmid":"35764091","id":"PMC_35764091","title":"An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/35764091","citation_count":46,"is_preprint":false},{"pmid":"28373485","id":"PMC_28373485","title":"Identification and characterization of a novel DGAT1 missense mutation associated with congenital diarrhea.","date":"2017","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/28373485","citation_count":46,"is_preprint":false},{"pmid":"14762086","id":"PMC_14762086","title":"The DGAT1 K232A mutation is not solely responsible for the milk production quantitative trait locus on the bovine chromosome 14.","date":"2004","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/14762086","citation_count":45,"is_preprint":false},{"pmid":"15163627","id":"PMC_15163627","title":"Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15163627","citation_count":45,"is_preprint":false},{"pmid":"15380446","id":"PMC_15380446","title":"Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion.","date":"2004","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/15380446","citation_count":43,"is_preprint":false},{"pmid":"35732120","id":"PMC_35732120","title":"Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35732120","citation_count":43,"is_preprint":false},{"pmid":"26898284","id":"PMC_26898284","title":"Effects of the diacylglycerol o-acyltransferase 1 (DGAT1) K232A polymorphism on fatty acid, protein, and mineral composition of dairy cattle milk.","date":"2016","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/26898284","citation_count":43,"is_preprint":false},{"pmid":"22291164","id":"PMC_22291164","title":"Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in mice.","date":"2012","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/22291164","citation_count":42,"is_preprint":false},{"pmid":"38500157","id":"PMC_38500157","title":"The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38500157","citation_count":40,"is_preprint":false},{"pmid":"26883093","id":"PMC_26883093","title":"Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations.","date":"2016","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26883093","citation_count":40,"is_preprint":false},{"pmid":"34485439","id":"PMC_34485439","title":"Association of DGAT1 With Cattle, Buffalo, Goat, and Sheep Milk and Meat Production Traits.","date":"2021","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/34485439","citation_count":38,"is_preprint":false},{"pmid":"15576838","id":"PMC_15576838","title":"DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content.","date":"2004","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15576838","citation_count":38,"is_preprint":false},{"pmid":"27179362","id":"PMC_27179362","title":"ATGL and DGAT1 are involved in the turnover of newly synthesized triacylglycerols in hepatic stellate cells.","date":"2016","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/27179362","citation_count":37,"is_preprint":false},{"pmid":"24954424","id":"PMC_24954424","title":"Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors.","date":"2014","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/24954424","citation_count":36,"is_preprint":false},{"pmid":"29024407","id":"PMC_29024407","title":"Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C/EBPα-p300/DGAT1 pathway.","date":"2017","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/29024407","citation_count":35,"is_preprint":false},{"pmid":"15114494","id":"PMC_15114494","title":"New Polyacetylenes, DGAT inhibitors from the roots of Panax ginseng.","date":"2004","source":"Planta medica","url":"https://pubmed.ncbi.nlm.nih.gov/15114494","citation_count":34,"is_preprint":false},{"pmid":"26142855","id":"PMC_26142855","title":"Effects of the DGAT1 polymorphism on test-day milk production traits throughout lactation.","date":"2015","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/26142855","citation_count":32,"is_preprint":false},{"pmid":"23501244","id":"PMC_23501244","title":"Association of polymorphisms at DGAT1, leptin, SCD1, CAPN1 and CAST genes with color, marbling and water holding capacity in meat from beef cattle populations in Sweden.","date":"2013","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/23501244","citation_count":30,"is_preprint":false},{"pmid":"16840633","id":"PMC_16840633","title":"Characterization of the DGAT1 mutations and the CSN1S1 promoter in the German Angeln dairy cattle population.","date":"2006","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/16840633","citation_count":30,"is_preprint":false},{"pmid":"17087837","id":"PMC_17087837","title":"DGAT1 and ABCG2 polymorphism in Indian cattle (Bos indicus) and buffalo (Bubalus bubalis) breeds.","date":"2006","source":"BMC veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/17087837","citation_count":29,"is_preprint":false},{"pmid":"15200432","id":"PMC_15200432","title":"Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.","date":"2004","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/15200432","citation_count":29,"is_preprint":false},{"pmid":"19781040","id":"PMC_19781040","title":"Effects of DGAT1 and GHR on milk yield and milk composition in the Chinese dairy population.","date":"2009","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19781040","citation_count":28,"is_preprint":false},{"pmid":"28222675","id":"PMC_28222675","title":"Identification and characterization of an efficient acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) gene from the microalga Chlorella ellipsoidea.","date":"2017","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/28222675","citation_count":28,"is_preprint":false},{"pmid":"32138658","id":"PMC_32138658","title":"Genome-wide identification of Diacylglycerol Acyltransferases (DGAT) family genes influencing Milk production in Buffalo.","date":"2020","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32138658","citation_count":27,"is_preprint":false},{"pmid":"31331203","id":"PMC_31331203","title":"In silico design of diacylglycerol acyltransferase-1 (DGAT1) inhibitors based on SMILES descriptors using Monte-Carlo method.","date":"2019","source":"SAR and QSAR in environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/31331203","citation_count":27,"is_preprint":false},{"pmid":"33757551","id":"PMC_33757551","title":"Ectopic overexpression of a type-II DGAT (CeDGAT2-2) derived from oil-rich tuber of Cyperus esculentus enhances accumulation of oil and oleic acid in tobacco leaves.","date":"2021","source":"Biotechnology for biofuels","url":"https://pubmed.ncbi.nlm.nih.gov/33757551","citation_count":26,"is_preprint":false},{"pmid":"20374941","id":"PMC_20374941","title":"Comparative genomics and proteomics of vertebrate diacylglycerol acyltransferase (DGAT), acyl CoA wax alcohol acyltransferase (AWAT) and monoacylglycerol acyltransferase (MGAT).","date":"2009","source":"Comparative biochemistry and physiology. Part D, Genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/20374941","citation_count":25,"is_preprint":false},{"pmid":"33824421","id":"PMC_33824421","title":"Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33824421","citation_count":25,"is_preprint":false},{"pmid":"36603576","id":"PMC_36603576","title":"DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma.","date":"2023","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36603576","citation_count":24,"is_preprint":false},{"pmid":"33750350","id":"PMC_33750350","title":"Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer.","date":"2021","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33750350","citation_count":24,"is_preprint":false},{"pmid":"21883511","id":"PMC_21883511","title":"DGAT1, GH, GHR, PRL and PRLR polymorphism in water buffalo (Bubalus bubalis).","date":"2011","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/21883511","citation_count":23,"is_preprint":false},{"pmid":"16595853","id":"PMC_16595853","title":"Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin.","date":"2006","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16595853","citation_count":23,"is_preprint":false},{"pmid":"25771043","id":"PMC_25771043","title":"Effect of the DGAT1 K232A genotype of dairy cows on the milk metabolome and proteome.","date":"2015","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/25771043","citation_count":23,"is_preprint":false},{"pmid":"31532486","id":"PMC_31532486","title":"Functional Characterization of Three Novel Genes Encoding Diacylglycerol Acyltransferase (DGAT) from Oil-Rich Tubers of Cyperus esculentus.","date":"2020","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31532486","citation_count":22,"is_preprint":false},{"pmid":"24344740","id":"PMC_24344740","title":"Aphadilactones A-D, four diterpenoid dimers with DGAT inhibitory and antimalarial activities from a Meliaceae plant.","date":"2013","source":"The Journal of organic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24344740","citation_count":22,"is_preprint":false},{"pmid":"32565248","id":"PMC_32565248","title":"Differential actions of diacylglycerol acyltransferase (DGAT) 1 and 2 in regulating lipid metabolism and progesterone secretion of goose granulosa cells.","date":"2020","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32565248","citation_count":21,"is_preprint":false},{"pmid":"25405858","id":"PMC_25405858","title":"Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25405858","citation_count":21,"is_preprint":false},{"pmid":"14683457","id":"PMC_14683457","title":"DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus.","date":"2003","source":"Current drug targets. Immune, endocrine and metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/14683457","citation_count":21,"is_preprint":false},{"pmid":"25349648","id":"PMC_25349648","title":"Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety.","date":"2014","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/25349648","citation_count":21,"is_preprint":false},{"pmid":"38293685","id":"PMC_38293685","title":"Prevention of lipid droplet accumulation by DGAT1 inhibition ameliorates sepsis-induced liver injury and inflammation.","date":"2023","source":"JHEP reports : innovation in hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/38293685","citation_count":20,"is_preprint":false},{"pmid":"35181144","id":"PMC_35181144","title":"Role of diacylglycerol O-acyltransferase (DGAT) isoforms in bovine hepatic fatty acid metabolism.","date":"2022","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/35181144","citation_count":20,"is_preprint":false},{"pmid":"31779717","id":"PMC_31779717","title":"Significant genetic effects of JAK2 and DGAT1 mutations on milk fat content and mastitis resistance in Holsteins.","date":"2019","source":"The Journal of dairy research","url":"https://pubmed.ncbi.nlm.nih.gov/31779717","citation_count":20,"is_preprint":false},{"pmid":"26942218","id":"PMC_26942218","title":"Phosphorylation and function of DGAT1 in skeletal muscle cells.","date":"2015","source":"Biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/26942218","citation_count":19,"is_preprint":false},{"pmid":"25152299","id":"PMC_25152299","title":"Deconstructing the DGAT1 enzyme: Binding sites and substrate interactions.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25152299","citation_count":19,"is_preprint":false},{"pmid":"30718413","id":"PMC_30718413","title":"DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30718413","citation_count":19,"is_preprint":false},{"pmid":"18704537","id":"PMC_18704537","title":"Effect of CLA and other C18 unsaturated fatty acids on DGAT in bovine milk fat biosynthetic systems.","date":"2008","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/18704537","citation_count":19,"is_preprint":false},{"pmid":"31315900","id":"PMC_31315900","title":"DGAT2 partially compensates for lipid-induced ER stress in human DGAT1-deficient intestinal stem cells.","date":"2019","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/31315900","citation_count":19,"is_preprint":false},{"pmid":"19412626","id":"PMC_19412626","title":"Cloning and molecular characterization of the acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) gene from Echium.","date":"2009","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/19412626","citation_count":19,"is_preprint":false},{"pmid":"39505261","id":"PMC_39505261","title":"Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells.","date":"2024","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/39505261","citation_count":18,"is_preprint":false},{"pmid":"27344248","id":"PMC_27344248","title":"Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27344248","citation_count":18,"is_preprint":false},{"pmid":"32480992","id":"PMC_32480992","title":"Characterisation of DGAT1 and DGAT2 from Jatropha curcas and their functions in storage lipid biosynthesis.","date":"2014","source":"Functional plant biology : FPB","url":"https://pubmed.ncbi.nlm.nih.gov/32480992","citation_count":18,"is_preprint":false},{"pmid":"36768334","id":"PMC_36768334","title":"Transmembrane Protein 68 Functions as an MGAT and DGAT Enzyme for Triacylglycerol Biosynthesis.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36768334","citation_count":18,"is_preprint":false},{"pmid":"39418169","id":"PMC_39418169","title":"Glycerol Kinase Drives Hepatic de novo Lipogenesis and Triglyceride Synthesis in Nonalcoholic Fatty Liver by Activating SREBP-1c Transcription, Upregulating DGAT1/2 Expression, and Promoting Glycerol Metabolism.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39418169","citation_count":17,"is_preprint":false},{"pmid":"17592768","id":"PMC_17592768","title":"Molecular cloning and single nucleotide polymorphism detection of buffalo DGAT1 gene.","date":"2007","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17592768","citation_count":17,"is_preprint":false},{"pmid":"30397187","id":"PMC_30397187","title":"Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2.","date":"2018","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/30397187","citation_count":17,"is_preprint":false},{"pmid":"23871442","id":"PMC_23871442","title":"Defining the key pharmacophore elements of PF-04620110: discovery of a potent, orally-active, neutral DGAT-1 inhibitor.","date":"2013","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23871442","citation_count":17,"is_preprint":false},{"pmid":"24578031","id":"PMC_24578031","title":"The utilization of the acyl-CoA and the involvement PDAT and DGAT in the biosynthesis of erucic acid-rich triacylglycerols in Crambe seed oil.","date":"2014","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/24578031","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50866,"output_tokens":7188,"usd":0.130209},"stage2":{"model":"claude-opus-4-6","input_tokens":10857,"output_tokens":3539,"usd":0.21414},"total_usd":0.344349,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"DGAT1 (Dgat) catalyzes the final and only committed step in triglyceride synthesis via the glycerol phosphate pathway; Dgat-deficient mice are viable and lean, demonstrating that Dgat1 is not absolutely required for survival but is necessary for normal triglyceride synthesis in adipose tissue and for lactation\",\n      \"method\": \"Genetic knockout (Dgat-/- mice), tissue triglyceride assays, phenotypic analysis of obesity resistance and lactation defects\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and physiological phenotypes, foundational study with >680 citations\",\n      \"pmids\": [\"10802663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DGAT1 is a multifunctional acyltransferase: beyond triacylglycerol synthesis, it also catalyzes synthesis of diacylglycerols (monoacylglycerol acyltransferase activity), wax monoesters and wax diesters (wax synthase activity), and retinyl esters (acyl-CoA:retinol acyltransferase/ARAT activity) in vitro and in vivo\",\n      \"method\": \"In vitro acyltransferase assays with microsomes from insect cells and COS7 cells overexpressing DGAT1; intact cell assays; DGAT1-deficient mice showing reduced ARAT activity and elevated hepatic unesterified retinol\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro enzymatic assays plus KO mouse validation, multiple orthogonal methods\",\n      \"pmids\": [\"15834126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DGAT1 topology: three transmembrane domains with the N-terminus oriented toward the cytosol and the large C-terminal region (~50% of protein) residing in the ER lumen; a conserved histidine (His-426) in the luminal C-terminal domain is a putative active-site residue required for triacylglycerol, retinyl ester, and wax ester synthesis; the N-terminal domain is not required for catalytic activity but is involved in dimer/tetramer formation\",\n      \"method\": \"Protease protection assays, indirect immunofluorescence with selective membrane permeabilization, site-directed mutagenesis (H426A) with in vitro acyltransferase assays, N-terminal truncation mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple structural/topological methods combined with mutagenesis and enzymatic assays in a single study\",\n      \"pmids\": [\"20876538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Liver-specific overexpression of DGAT1 increases DGAT activity detectable only in the presence of the permeabilizing agent alamethicin, indicating that DGAT1 possesses latent DGAT activity on the luminal face of the ER membrane; hepatic DGAT1 overexpression increases VLDL secretion, resulting in increased gonadal fat mass\",\n      \"method\": \"Adenovirus-mediated hepatic overexpression of DGAT1 in mice; DGAT activity assays with and without alamethicin permeabilization; plasma VLDL measurements; fat depot analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain-of-function with biochemical enzyme activity assays demonstrating luminal orientation\",\n      \"pmids\": [\"15797871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DGAT1 and DGAT2 together account for nearly all triacylglycerol synthesis in adipocytes and are required for lipid droplet formation during adipogenesis; adipocytes lacking both DGATs have no TG or lipid droplets despite full differentiation; single deletion of either enzyme alone is insufficient to block TG synthesis\",\n      \"method\": \"Genetic double knockout (DGAT1 and DGAT2 adipocyte deletions), TG quantification, lipid droplet imaging, differentiation marker analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via double KO with defined cellular phenotype, multiple methods\",\n      \"pmids\": [\"21317108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FA re-esterification during adipocyte lipolysis is mediated specifically by DGAT1 (ER-localized); this re-esterification cycle does not preserve TG mass but instead protects the ER from lipotoxic stress and adipose tissue inflammation; mice lacking DGAT1 in adipocytes show activated ER stress pathways specifically under high-fat diet challenge\",\n      \"method\": \"Adipocyte-specific DGAT1 knockout mice, lipolysis assays, ER stress marker analysis, adipose tissue inflammation measurements, high-fat diet challenge\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with defined ER stress phenotype, replicated across multiple readouts\",\n      \"pmids\": [\"28768178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In hepatocytes, DGAT1 preferentially esterifies exogenous (dietary/plasma) fatty acids into TG (re-esterification pathway), while DGAT2 primarily incorporates endogenously synthesized fatty acids into TG; DGAT1 inhibition reduces incorporation of exogenous oleic acid into VLDL-TG without affecting glycerol-derived (de novo) TG synthesis\",\n      \"method\": \"Stable isotope tracing with 13C3-D5-glycerol and 13C18-oleic acid in HepG2 cells; selective DGAT1 and DGAT2 inhibitors; in vivo D5-glycerol and 13C18-oleic acid tracing in mice with DGAT2 antisense oligonucleotide knockdown; LC-MS/MS lipidomics\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — isotope tracing with selective inhibitors in vitro and in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"22493088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The bovine DGAT1 K232A polymorphism is functionally causative: the K allele has higher Vmax for triglyceride production than the A allele, as demonstrated by baculovirus expression of both alleles in Sf9 cells\",\n      \"method\": \"Baculovirus expression system in Sf9 insect cells; DGAT enzymatic kinetics (Vmax) comparing K and A alleles; high-density SNP mapping confirming DGAT1 as QTL locus\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic reconstitution with allele comparison, replicated by genetic association\",\n      \"pmids\": [\"14983021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Cardiomyocyte-specific loss of DGAT1 causes DAG and ceramide accumulation (95% and 85% increases respectively), heart failure, and early mortality; loss of DGAT1-mediated conversion of DAG to TG leads to increased PKCα activation by accumulated DAG/ceramides; restriction of dietary fat absorption via enterocyte-specific DGAT1 KO or GLP-1 agonist exenatide corrects these lipid abnormalities and cardiac dysfunction\",\n      \"method\": \"Cardiomyocyte-specific DGAT1 KO mice; DAG and ceramide quantification; cardiac function measurements (fractional shortening, BNP); genetic epistasis with enterocyte-specific Dgat1 KO; pharmacological treatment with exenatide\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with defined lipid metabolite and cardiac phenotypes, epistasis rescue experiments\",\n      \"pmids\": [\"25157099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DGAT1 expression in macrophages determines their TG storage capacity and inversely regulates inflammatory activation by saturated fatty acids; macrophage-specific DGAT1 overexpression protects against diet-induced adipose tissue inflammation and insulin resistance; PPARγ agonist protective effects against FA-induced macrophage inflammation are absent in Dgat1-null macrophages\",\n      \"method\": \"Bone marrow transplantation, macrophage-specific overexpression (aP2-Dgat1), macrophage isolation with TG measurement, inflammatory cytokine assays, PPARγ agonist treatment of Dgat1-null macrophages\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific overexpression and KO with BM transplantation epistasis and defined inflammatory phenotypes\",\n      \"pmids\": [\"20124729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Intestinal DGAT1 stimulates dietary fat secretion out of enterocytes into circulation; intestinal DGAT1 expression alone (without liver or adipose DGAT1) is sufficient to reconstitute susceptibility to high-fat diet-induced hepatic steatosis and obesity in Dgat1-/- mice\",\n      \"method\": \"Intestine-specific rescue of DGAT1 expression in Dgat1-/- mice (Dgat1IntONLY), high-fat diet challenge, hepatic steatosis measurement, obesity phenotyping\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific rescue epistasis experiment with defined metabolic phenotype\",\n      \"pmids\": [\"20147738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Intestinal DGAT1 inhibition or deficiency reduces postprandial TG and retinyl ester excursions by inhibiting chylomicron secretion; loss of intestinal DGAT1 activity delays gastric emptying and increases plasma GLP-1; the chylomicron secretion defect occurs independently of gastric emptying delay when lipid is delivered directly to the small intestine\",\n      \"method\": \"Intestine-specific Dgat1 KO mice, acute DGAT1 inhibitor gavage, oral fat/retinol loading, chylomicron secretion assays, GLP-1 measurement, duodenal oil injection bypass experiments\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with pharmacological inhibition and multiple mechanistic dissection experiments\",\n      \"pmids\": [\"22911105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hepatic DGAT1 determines VLDL particle size and TG content but not particle number; DGAT1-LKO hepatocytes secrete VLDL particles with half the normal TG content and size; this is consistent with DGAT1's dual ER membrane topology enabling TAG synthesis on the luminal side for full VLDL lipidation; DGAT2 can fully support apoB secretion (particle number) in absence of DGAT1\",\n      \"method\": \"Hepatocyte-specific DGAT1 KO mice (DGAT1-LKO), Triton WR-1339 VLDL secretion assay, VLDL particle sizing, apoB concentration measurement, ER lipid content analysis by electron microscopy, HepG2 cells with isoform-selective inhibitors\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — hepatocyte-specific KO with biochemical characterization of VLDL particles and ER lipid content, consistent with established topology\",\n      \"pmids\": [\"30397187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DGAT1 and DGAT2 have distinct but overlapping functions in adipocytes: DGAT2-specific KO in adipocytes does not impair TG storage or glucose metabolism, while DGAT1-specific KO causes glucose intolerance and ER stress pathway activation on high-fat diets; DGAT1 uniquely protects the ER from lipotoxic stress of high-fat feeding\",\n      \"method\": \"Adipocyte-specific DGAT1 and DGAT2 KO mice, high-fat diet challenge, TG quantification, glucose tolerance tests, ER stress marker analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — parallel cell-type-specific KO models with defined metabolic and ER stress phenotypes\",\n      \"pmids\": [\"30936184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DGAT1 deficiency in mice impairs mammary gland development: decreased epithelial proliferation, alveolar development, and reduced expression of functional differentiation markers; transplantation studies show DGAT1 is required in both stromal and epithelial tissues for normal mammary development\",\n      \"method\": \"Dgat1-/- mice, mammary gland transplantation (wild-type vs. Dgat1-/- stroma/epithelium combinations), proliferation and differentiation marker analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue transplantation epistasis with defined developmental phenotype\",\n      \"pmids\": [\"15163627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DGAT1 acyltransferase activity sequesters retinol as retinyl esters, thereby preventing retinol conversion to retinoic acid and suppressing retinoic acid-dependent regulatory T cell (Treg) formation; DGAT1 inhibition or deficiency in T cells enhances Treg frequency and attenuates experimental autoimmune encephalomyelitis\",\n      \"method\": \"Dgat1-/- mice in EAE model, adoptive transfer of Dgat1-/- Th17 cells, DGAT1 inhibitor treatment, in vitro Treg induction assays with retinol, T cell-depleted lymphoid tissue cultures\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO and pharmacological inhibition with mechanistic retinol/retinoic acid pathway dissection in multiple in vitro and in vivo experiments\",\n      \"pmids\": [\"30718413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HILPDA (hypoxia-inducible lipid droplet-associated protein) physically interacts with DGAT1 in living liver cells and stimulates DGAT activity, increasing DGAT1 protein levels and promoting lipid storage in hepatocytes and adipocytes\",\n      \"method\": \"FRET-FLIM in live cells confirming physical interaction, real-time fluorescence live-cell imaging, DGAT activity assays, HILPDA overexpression and deficiency models\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — FRET-FLIM physical interaction in living cells plus functional enzymatic activity assays and KO/OE models\",\n      \"pmids\": [\"33465519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SARS-CoV-2 nucleocapsid protein drives DGAT1/2 gene expression to facilitate lipid droplet formation; DGAT1 gene depletion reduces SARS-CoV-2 protein synthesis without compromising viral genome replication/transcription, indicating DGAT1-dependent lipid droplets are required for a post-replication step in the viral cycle\",\n      \"method\": \"DGAT gene depletion (siRNA/CRISPR), viral protein vs. genome replication quantification, lipid droplet imaging, DGAT inhibitor xanthohumol in hamster model\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic depletion with mechanistic dissection of viral lifecycle steps, single lab study\",\n      \"pmids\": [\"34702802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DGAT1 in skeletal muscle cells is phosphorylated at multiple sites; phosphorylation at specific conserved residues regulates DGAT1 enzymatic activity; a defined N-terminal domain of DGAT1 influences regulatory activity; these phosphorylation events were confirmed by mass spectrometry of purified DGAT1 from C2C12 myoblasts\",\n      \"method\": \"Phosphorylation mass spectrometry of purified DGAT1 from C2C12 cells, site-directed mutagenesis of phosphorylation sites, truncation mutants with enzymatic activity assays\",\n      \"journal\": \"Biophysics reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mass spectrometry identification combined with mutagenesis functional assays, single lab study\",\n      \"pmids\": [\"26942218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DGAT1 substrate binding sites include a luminal loop containing the FYxDWWN motif (Sit1, shared with ACAT enzymes) that changes conformation upon binding both oleoyl-CoA and diacylglycerol substrates, and a diacylglycerol-binding domain (Sit2, HKWCIRHFYKP motif) that interacts with charged headgroups; in a peptide containing both sites, larger conformational changes are induced, suggesting the two sites bring substrates into proximity for catalysis\",\n      \"method\": \"Synchrotron radiation circular dichroism spectroscopy of synthetic peptides, fluorescence emission spectroscopy, lipid monolayer adsorption assays with substrates oleoyl-CoA and dioleoylglycerol\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods on defined peptides, but indirect (peptide-based) rather than full protein structure\",\n      \"pmids\": [\"25152299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A novel DGAT1 missense mutation p.L105P causes partial loss of DGAT1 enzymatic activity and decreased TG synthesis and lipid droplet formation in patient-derived fibroblasts, demonstrating that DGAT1 protein stability and quantity affect TG synthesis capacity\",\n      \"method\": \"Exome sequencing, patient-derived primary dermal fibroblasts, DGAT1 protein abundance measurement, TG synthesis assays, lipid droplet quantification after oleic acid loading\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived cell functional assays with defined biochemical readouts, single center\",\n      \"pmids\": [\"28373485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Biallelic loss-of-function mutations in human DGAT1 cause intestinal failure with altered triacylglycerol metabolism, decreased lipid droplet formation, and increased susceptibility to lipid-induced cell death; expression of full-length DGAT2 in DGAT1-deficient fibroblasts restores lipid droplet formation, demonstrating functional overlap between the two enzymes\",\n      \"method\": \"Next-generation sequencing identifying 5 biallelic DGAT1 mutations, patient-derived intestinal organoids and fibroblasts, immunoblot, flow cytometry, lipid chromatography, caspase 3/7 activity assays, DGAT2 rescue experiments, CRISPR/Cas9 DGAT1 disruption in control organoids\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple patient-derived cell systems with orthogonal methods plus rescue experiments, large patient cohort\",\n      \"pmids\": [\"29604290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DGAT1 overexpression in skeletal muscle by in vivo electroporation directly increases intramyocellular lipid (IMCL) storage in a diet-responsive manner, demonstrating that DGAT1 activity directly controls TG storage in muscle\",\n      \"method\": \"In vivo DNA electroporation of pcDNA3.1-DGAT1 into tibialis anterior muscle, immunofluorescence for DGAT1 protein expression, quantitative IMCL analysis with lipid staining\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo gain-of-function with quantitative lipid phenotype, single lab\",\n      \"pmids\": [\"15576838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DGAT1 in intestinal L-cells directly regulates GLP-1 and PYY secretion; DGAT1KO mice show prolonged GLP-1 and PYY elevation after triglyceride loading compared to wild-type, while GIP increase is suppressed; STC-1 and GLUTag L-cell lines possess DGAT1 activity but not MGAT activity\",\n      \"method\": \"DGAT1KO and MGAT2KO mouse oral triglyceride loading studies, plasma gut peptide measurements (GIP, GLP-1, PYY), gastric emptying measurements, DGAT/MGAT activity assays in L-cell lines\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse studies with biochemical cell-line validation, single lab\",\n      \"pmids\": [\"19732742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Ghrelin deletion prevents age-associated DGAT1 upregulation in liver by reducing formation of C/EBPα-p300 transcriptional complexes that bind and activate the DGAT1 promoter; in aged wild-type mice, C/EBPα-p300 complexes bind the DGAT1 promoter and increase DGAT1 expression, driving steatosis\",\n      \"method\": \"Ghrelin KO mice, ChIP analysis showing C/EBPα-p300 occupancy of DGAT1 promoter, co-immunoprecipitation of C/EBPα-p300 complexes, DGAT1 promoter binding studies, aged mouse hepatic steatosis analysis\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and Co-IP demonstrating transcriptional complex binding to DGAT1 promoter, single lab\",\n      \"pmids\": [\"29024407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In clear cell renal cell carcinoma, the epigenetic enzyme JMJD6 interacts with RBM39 and co-occupies the DGAT1 gene promoter with H3K4me3 to induce DGAT1 expression; DGAT1 upregulation promotes lipid droplet formation required for ccRCC tumorigenesis\",\n      \"method\": \"siRNA screen, ChIP-seq and RNA-seq integration, Co-IP of JMJD6-RBM39 interaction, DGAT1 KD and pharmacological inhibition, orthotopic tumor models in vivo\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq, Co-IP and in vivo tumor models in single study, mechanistic pathway defined\",\n      \"pmids\": [\"35764091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In hepatic stellate cells, DGAT1 synthesizes newly formed TAG enriched in PUFAs; ATGL preferentially degrades these newly synthesized DGAT1-dependent TAGs; DGAT1 inhibitor T863 reduces PUFA-TAG synthesis in HSCs\",\n      \"method\": \"Targeted Atgl gene deletion in mouse HSCs, DGAT1 inhibitor T863, lipidomics of TAG species, hepatic stellate cell activation assays\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with pharmacological inhibition and lipidomic characterization, single lab\",\n      \"pmids\": [\"27179362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In DGAT1-deficient human intestinal stem cell organoids, DGAT2 partially compensates for lipid droplet formation; unsaturated and saturated FA-induced lipotoxicity in DGAT1-deficient cells is mediated by ER stress; DGAT2 overexpression fully rescues DGAT1 deficiency in organoids\",\n      \"method\": \"Patient-derived DGAT1-deficient intestinal organoids, DGAT2 overexpression rescue, ER stress marker analysis, lipid droplet quantification, FA lipotoxicity assays\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived organoid rescue experiments with mechanistic ER stress pathway analysis, single lab\",\n      \"pmids\": [\"31315900\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DGAT1 is an ER-resident integral membrane enzyme with three transmembrane domains and a large catalytic C-terminal domain in the ER lumen (containing the active-site His-426) that catalyzes the final committed step of triacylglycerol synthesis by acylating diacylglycerol using acyl-CoA; it also functions as a monoacylglycerol acyltransferase, wax synthase, and retinol acyltransferase (ARAT), and its dual ER topology enables both cytosolic and luminal TG synthesis—with the luminal activity being critical for full VLDL lipidation; beyond bulk TG storage, DGAT1 specifically re-esterifies exogenous fatty acids and protects the ER from lipotoxic stress during lipolysis, controls retinol availability for retinoic acid synthesis in T cells, regulates gut peptide (GLP-1/PYY) secretion in intestinal L-cells, and is transcriptionally regulated by C/EBPα-p300 complexes and the JMJD6-RBM39 epigenetic axis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DGAT1 is an ER-resident acyltransferase that catalyzes the final committed step of triacylglycerol (TG) synthesis and additionally functions as a monoacylglycerol acyltransferase, wax synthase, and retinol acyltransferase (ARAT), with a catalytic His-426 residue in its large ER-luminal C-terminal domain [PMID:15834126, PMID:20876538]. Its dual ER membrane topology enables both cytosolic and luminal TG synthesis; the luminal activity is specifically required for full VLDL lipidation in hepatocytes and for chylomicron secretion in enterocytes, while it preferentially esterifies exogenous rather than de novo–synthesized fatty acids [PMID:15797871, PMID:30397187, PMID:22493088]. Beyond bulk lipid storage, DGAT1-mediated re-esterification of fatty acids released during lipolysis protects the ER from lipotoxic stress, and its ARAT activity controls retinol availability for retinoic acid–dependent regulatory T cell differentiation [PMID:28768178, PMID:30936184, PMID:30718413]. Biallelic loss-of-function mutations in human DGAT1 cause congenital diarrhea and intestinal failure with impaired TG metabolism and increased susceptibility to lipid-induced cell death [PMID:29604290].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that DGAT1 is the terminal enzyme in the glycerol phosphate TG synthesis pathway and is required for normal adiposity and lactation—but is not essential for viability—defined its non-redundant physiological role and implied the existence of compensatory pathways.\",\n      \"evidence\": \"Dgat1 global knockout mice with phenotypic and tissue TG analysis\",\n      \"pmids\": [\"10802663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity and contribution of the compensating enzyme (DGAT2) not yet defined\", \"Tissue-specific requirements not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstration that DGAT1 directly controls intramyocellular and mammary lipid storage, and that a naturally occurring bovine K232A polymorphism alters enzymatic Vmax, established DGAT1 activity as rate-limiting for tissue TG content and showed genetic variation at the locus has quantitative functional consequences.\",\n      \"evidence\": \"In vivo muscle electroporation gain-of-function; mammary transplantation epistasis; baculovirus reconstitution of K vs A alleles with kinetic assays\",\n      \"pmids\": [\"14983021\", \"15576838\", \"15163627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-translational regulation of DGAT1 activity unknown\", \"Structural basis for K232A kinetic difference unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovering DGAT1's multifunctional acyltransferase repertoire (MGAT, wax synthase, ARAT) and its latent luminal DGAT activity that promotes VLDL secretion revealed that the enzyme operates on both sides of the ER membrane and handles diverse lipid substrates.\",\n      \"evidence\": \"In vitro microsome assays with multiple substrates; Dgat1-KO mouse retinol metabolism; hepatic adenoviral overexpression with alamethicin-dependent activity assays and VLDL measurement\",\n      \"pmids\": [\"15834126\", \"15797871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for multisubstrate promiscuity unknown\", \"Relative contribution of luminal vs cytosolic activity in vivo not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification that DGAT1 in intestinal L-cells regulates GLP-1 and PYY secretion linked TG esterification to gut incretin signaling, expanding DGAT1's role beyond lipid storage to neuroendocrine regulation.\",\n      \"evidence\": \"Dgat1-KO and Mgat2-KO mouse oral TG loading with gut peptide measurement; DGAT/MGAT activity assays in L-cell lines\",\n      \"pmids\": [\"19732742\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which intracellular TG flux regulates peptide vesicle secretion undefined\", \"Contribution of DGAT1 vs other lipid metabolic steps in L-cells not fully separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Elucidation of DGAT1 membrane topology (three TMDs, luminal catalytic domain with essential His-426) and demonstration that macrophage DGAT1 inversely controls inflammatory activation resolved how the enzyme is oriented in the ER and established a cell-autonomous anti-inflammatory function through FA sequestration.\",\n      \"evidence\": \"Protease protection, selective permeabilization, site-directed mutagenesis; bone marrow transplant with macrophage-specific overexpression and KO\",\n      \"pmids\": [\"20876538\", \"20124729\", \"20147738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution 3D structure not available\", \"Mechanism of oligomerization via N-terminal domain not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Double knockout of DGAT1 and DGAT2 in adipocytes completely abolished TG and lipid droplets while single knockouts did not, formally proving functional redundancy yet also demonstrating that the two enzymes together account for virtually all adipocyte TG synthesis.\",\n      \"evidence\": \"Adipocyte-specific double KO with TG quantification and lipid droplet imaging\",\n      \"pmids\": [\"21317108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the two enzymes occupy distinct ER subdomains not addressed\", \"Lipid species specificity of each enzyme in adipocytes not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Isotope tracing established that DGAT1 preferentially esterifies exogenous fatty acids while DGAT2 handles de novo–synthesized ones, and that intestinal DGAT1 is required for chylomicron secretion independently of gastric emptying, delineating substrate-source partitioning between the two enzymes.\",\n      \"evidence\": \"13C-oleic acid and 13C3-D5-glycerol tracing with isoform-selective inhibitors in HepG2 and mice; intestine-specific Dgat1 KO with duodenal oil bypass\",\n      \"pmids\": [\"22493088\", \"22911105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular determinants of exogenous FA channeling to DGAT1 unknown\", \"Whether FA source specificity holds in all tissues untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Biophysical characterization of substrate-binding motifs (FYxDWWN and HKWCIRHFYKP) and demonstration that cardiomyocyte DGAT1 loss causes lethal DAG/ceramide accumulation and heart failure provided the first structure-function mapping of the active site and revealed that DGAT1-mediated DAG clearance is essential for cardiac lipid homeostasis.\",\n      \"evidence\": \"Synchrotron CD and fluorescence spectroscopy of synthetic peptides; cardiomyocyte-specific Dgat1 KO with lipidomics and cardiac function measurement\",\n      \"pmids\": [\"25152099\", \"25157099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Peptide-based substrate binding studies not validated in full-length protein\", \"How cardiac DGAT1 is regulated differently from adipocyte DGAT1 unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovery that DGAT1-mediated fatty acid re-esterification during lipolysis specifically protects the ER from lipotoxic stress—rather than preserving TG mass—redefined the enzyme's role as an ER quality-control mechanism, while identification of C/EBPα–p300 complex binding at the DGAT1 promoter established a transcriptional regulatory axis.\",\n      \"evidence\": \"Adipocyte-specific Dgat1 KO with ER stress markers under HFD; ChIP and Co-IP of C/EBPα–p300 on DGAT1 promoter in aged mouse liver\",\n      \"pmids\": [\"28768178\", \"29024407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ER lipid species causing stress in DGAT1-deficient cells not identified\", \"Whether C/EBPα–p300 regulation is universal or tissue-specific unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Hepatocyte-specific DGAT1 deletion showed that DGAT1 determines VLDL particle size and TG content (but not particle number), linking the enzyme's luminal activity to the second-step lipidation of VLDL; separately, biallelic human DGAT1 mutations were shown to cause congenital intestinal failure with lipotoxic cell death, establishing DGAT1 deficiency as a Mendelian disease.\",\n      \"evidence\": \"DGAT1-LKO mice with VLDL particle sizing; patient-derived organoids and fibroblasts from five DGAT1-mutant families with DGAT2 rescue and CRISPR validation\",\n      \"pmids\": [\"30397187\", \"29604290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How luminal TG pool is transferred to nascent VLDL particles mechanistically unresolved\", \"Genotype-phenotype correlation across different human mutations not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that DGAT1's ARAT activity sequesters retinol away from retinoic acid synthesis in T cells, thereby suppressing Treg differentiation, revealed an unexpected immunoregulatory function linking lipid metabolism to adaptive immunity.\",\n      \"evidence\": \"Dgat1-KO mice in EAE model, adoptive T cell transfer, DGAT1 inhibitor, in vitro Treg induction with retinol\",\n      \"pmids\": [\"30718413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DGAT1-dependent retinol esterification regulates other immune cell types untested\", \"Relative contribution of DGAT1 ARAT vs LRAT in T cell retinol homeostasis not quantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of HILPDA as a direct physical interactor that stimulates DGAT1 activity provided the first protein-level positive regulator of the enzyme, suggesting allosteric or stabilizing activation mechanisms.\",\n      \"evidence\": \"FRET-FLIM in live hepatocytes confirming physical interaction; DGAT activity assays with HILPDA OE/KO\",\n      \"pmids\": [\"33465519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface and mechanism of HILPDA-mediated activation undefined\", \"Whether HILPDA affects DGAT1 oligomeric state unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that the JMJD6–RBM39 epigenetic complex co-occupies the DGAT1 promoter with H3K4me3 to drive DGAT1 expression in clear cell renal cell carcinoma established a second transcriptional regulatory axis and implicated DGAT1-dependent lipid droplets in tumor biology.\",\n      \"evidence\": \"ChIP-seq, RNA-seq, Co-IP of JMJD6–RBM39, DGAT1 KD and inhibition in orthotopic ccRCC tumor models\",\n      \"pmids\": [\"35764091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether JMJD6–RBM39 regulation of DGAT1 occurs in non-malignant tissues unknown\", \"Mechanism by which DGAT1-dependent LDs support ccRCC viability not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of full-length DGAT1 in complex with substrates and regulatory partners (e.g., HILPDA) is needed to explain multisubstrate promiscuity, the structural basis for oligomerization, and how phosphorylation at identified sites modulates activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length human DGAT1 structure with substrates bound\", \"Phosphorylation-dependent regulation not integrated with topology and structural models\", \"Allosteric mechanism of HILPDA activation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 7]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 3, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 4, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [3, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"HILPDA\",\n      \"DGAT2\",\n      \"CEBPA\",\n      \"EP300\",\n      \"JMJD6\",\n      \"RBM39\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}